Pharmaceutical

< Back to Health Reform Resource Center

Stay tuned to this section for important implementation documents for Pharmaceutical. Ropes & Gray will track the many upcoming regulatory issuances and other implementation materials and deadlines as health reform is rolled out, and will place them here along with relevant analysis

ROPES & GRAY ANALYSIS

• Health Care Reform: Key Legislative Changes Impacting the Pharmaceutical, Biotechnology, and Medical Device Industries
  (March 30, 2010)
  
  
• Physician Payment “Sunshine Provisions” Signed into Law as Part of Health Care Reform Legislation
  (March 30, 2010)
  
  
• Congress Authorizes Abbreviated Regulatory Pathway for FDA Approval of Biological Products
  (March 30, 2010)
  
  
• Comprehensive Health Reform Expands Health Care Fraud and Abuse Law
  (March 29, 2010)
  
  
• Finding a Way to Pay for Health Reform
  (December 2009)
  
  
• Current Stakeholder Perspectives on Health Reform
  (December 2009)
  
  
• Reform Legislation Includes Regulatory Pathway for Follow-on Biologics
  (September 2009)

• CMS Memorandum: Additional Guidance on 2011 Coverage for Generic Drugs in the Coverage Gap
  (May 21, 2010)
  
  
• State Medicaid Directors Letter: Prescription Drug Rebates
  (April 22, 2010)
  
  
• State Medicaid Directors Letter on Medicaid Rebate Provisions in Health Reform
  (April 22, 2010)

---

©1996-2012 Ropes & Gray LLP. All rights reserved.